Endo Pharms Inc. et al. v. Sandoz, Inc.

(08-534 and 08-970 – KSH) (D Del.). Patent infringement action regarding Sandoz’s ANDA for Endo’s pain product Opana® ER (oxymorphone hydrochloride). Settled favorably for Sandoz.

View All Results
Every case is different and results depend on their specific circumstances. Prior results do not guarantee a similar outcome.